Literature DB >> 10785594

C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients.

R Kallio1, H M Surcel, A Bloigu, H Syrjälä.   

Abstract

The diagnostic utility of C-reactive protein (CRP), procalcitonin (PCT) and interleukin-8 (IL-8) were studied in 66 cancer patients with suspected infection (39 with definite foci of infection, 17 with antibiotic responses without foci and 10 with neoplastic fever without infection) and 26 patients scheduled for chemotherapy. The infection group (n=56) had higher median CRP (91 versus 19 mg/l, P<0. 001), PCT (0.28 versus 0.12 ng/ml, P<0.001) and IL-8 values (27.7 versus 16.9 pg/ml, P=0.032) than the non-infection group (n=36). In patients with suspected infection, only PCT was a good marker to discriminate bacteraemia with an area under the receiver operating characteristics curve of 0.92 (95% confidence interval (CI), 0.77-1. 0), but even PCT was less well able to differentiate between non-bacteraemic infections and neoplastic fever (0.56; 95% CI, 0. 35-0.77). In conclusion, PCT was a good indicator for bacteraemia, but none of the three markers were reliable indicators for minor infections in non-neutropenic cancer patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10785594     DOI: 10.1016/s0959-8049(00)00018-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  11 in total

1.  Diagnostic use of serum procalcitonin levels in pulmonary aspiration syndromes.

Authors:  Ali A El-Solh; Hardik Vora; Paul R Knight; Jahan Porhomayon
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

2.  Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies.

Authors:  M von Lilienfeld-Toal; A Schneider; K Orlopp; C Hahn-Ast; A Glasmacher; F Stüber
Journal:  Support Care Cancer       Date:  2006-05-30       Impact factor: 3.603

Review 3.  Biomarkers in the diagnosis of aspiration syndromes.

Authors:  Philippe Abou Jaoude; Paul R Knight; Patricia Ohtake; Ali A El-Solh
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

4.  Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.

Authors:  M von Lilienfeld-Toal; M P Dietrich; A Glasmacher; L Lehmann; P Breig; C Hahn; I G H Schmidt-Wolf; G Marklein; S Schroeder; F Stuber
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-22       Impact factor: 3.267

5.  Expression of CD11b/CD18 adhesion molecules on circulating phagocytes-a novel aid to diagnose infection in patients with cancer.

Authors:  R Kallio; H Aalto; A Takala; P Ohtonen; J Collan; S Siitonen; H Joensuu; H Syrjala; H Repo
Journal:  Support Care Cancer       Date:  2008-04-15       Impact factor: 3.603

6.  Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever.

Authors:  Nicolas Penel; Charles Fournier; Stéphanie Clisant; Michèle N'Guyen
Journal:  Support Care Cancer       Date:  2004-02-10       Impact factor: 3.603

7.  C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer.

Authors:  Nevin Ilhan; Necip Ilhan; Yavuz Ilhan; Handan Akbulut; Mehmet Kucuksu
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

8.  Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer.

Authors:  Marta Lukaszewicz-Zając; Barbara Mroczko; Mariusz Gryko; Bogusław Kędra; Maciej Szmitkowski
Journal:  Clin Exp Med       Date:  2010-10-12       Impact factor: 3.984

Review 9.  A systematic review of the association between circulating concentrations of C reactive protein and cancer.

Authors:  Katriina Heikkilä; Shah Ebrahim; Debbie A Lawlor
Journal:  J Epidemiol Community Health       Date:  2007-09       Impact factor: 3.710

10.  A novel marker procalcitonin may help stem the antibiotic overuse in emergency setting.

Authors:  Kamalpreet Kaur; Rajiv Mahajan; Aparna Tanwar
Journal:  Int J Appl Basic Med Res       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.